Table 4.
Beta 2 HPV E61 | HPV197 CE6 Unique/Total/Coverage | HPV197 NE6 Unique/Total/Coverage | |
---|---|---|---|
CNOT1 | HCIP | 100/137/43.98 % | 76/93/39.10 % |
CNOT2 | HCIP | 22/37/54.26 % | 14/18/47.04 % |
CNOT3 | HCIP | 16/21/27.49 % | 9/10/14.48 % |
CNOT4 | HCIP | 16/29/32.35 % | 13/18/27.48 % |
CNOT6 | HCIP | 6/6/24.78 % | 4/4/14.90 % |
CNOT6L | HCIP | 9/10/19.46 % | 8/9/16.76 % |
CNOT7 | HCIP | 9/13/49.12 % | 6/9/31.23 % |
CNOT8 | - | 7/7/38.70 % | 5/5/20.55 % |
RQCD1 (CNOT9) | HCIP | 11/14/37.79 % | 10/13/37.12 % |
CNOT10 | HCIP | 18/19/30.38 % | 10/10/20.43 % |
C2ORF29 (CNOT11) | HCIP | 11/13/30.78 % | 7/8/20.59 % |
data from (White et al., 2012a)